Search
Close this search box.

Home > Our Partners > Quanterix

Quanterix

About Quanterix

Quanterix is at the forefront of transforming healthcare through its commitment to precision medicine. Their mission is to revolutionize sick care by enabling earlier disease detection, prevention, and the development of next-generation treatments. Using cutting-edge technology, including the ultrasensitive Simoa® platform, they empower researchers to study biomarkers at unprecedented sensitivity levels, uncovering insights into critical therapeutic areas such as neurology, oncology, cardiology, inflammation, and infectious diseases.

With a strong global presence, Quanterix serves academic and industry customers directly in North America and Europe, and through distributor partnerships worldwide. Their expert team of field scientists and engineers provides robust support to researchers across the globe, ensuring success in their critical work.

Built on a foundation of innovation, collaboration, and scientific excellence, Quanterix is driving the future of healthcare by accelerating the discovery and application of novel biomarkers. They are committed to advancing the science of precision health and transforming the way the world approaches medicine.

Simoa® Technology

Revolutionizing Biomarker Detection
Quanterix’s Simoa® technology sets a new gold standard for biomarker sensitivity and precision. Detect proteins at femtogram levels in blood, serum, or plasma, enabling earlier disease diagnosis and groundbreaking research. Trusted across neurology, oncology, cardiology, immunology, and infectious disease, Simoa® drives innovation with ultrasensitive instruments, digital immunoassays, and CLIA-certified labs.

Key Features:

  • Unmatched sensitivity down to fg/mL levels.
  • Accelerates discovery and diagnostics.
  • Supports groundbreaking research globally.

Simoa® Bead Technology

Simoa® Bead Technology offers unprecedented sensitivity, revolutionizing how researchers study health and disease. By detecting biomarkers at ultra-low levels, it enables powerful insights into critical therapeutic areas such as neurology and oncology. With first-of-its-kind detection capabilities, femto-level sensitivity for early diagnosis, and rapid result delivery, Simoa Bead Technology is setting a new standard for precision in biomarker research.

How it works

Paramagnetic particles bind specific targets.

Detection antibodies generate a fluorescent signal.

Samples are analyzed in 200,000+ microwells, delivering precise data.

At low concentrations, each bead will contain one bound protein, or none.

The sample is loaded in the Simoa disc, consisting of more than 200,000 microwells

Enzymatic signal amplification with fluorescent substrate, imaging and data reduction.

Data analysis – results can be viewed and analyzed on the board or exported to LIMS systems.

Simoa® Planar Array Technology

Simoa® Planar Array Technology simplifies complex biomarker research with its robust and multiplexed analysis capabilities. Designed to address unmet needs in modern research, it combines exceptional flexibility, dynamic range, and precision. With the ability to measure up to 10 biomarkers in a single test, optimized fluid dynamics for enhanced reaction kinetics, and high-quality imaging for reliable results, Simoa Planar Array Technology delivers unparalleled performance for advanced biomarker analysis.

How it works

96-well plates spotted with target analytes.

Samples and standards added; vortex effect created.

Biotinylated detection antibodies form immunocomplex.

HRP enzyme-conjugated streptavidin added.

Chemiluminescent substrate enables CCD camera imaging.

Quanterix Portfolio

Let’s Find You an Application That Helps Your Research

Get a call from your local Decode Science representative to help you find the best fit genomics products for you.

    Or give us a call at:

    1300 581 991